Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Biofermin Pharmaceutical. (4517.TSE) Q2 2018 Earnings
4517.TSE
27
Jul
Expected
Q3 2017
Q4 2017
Q1 2018
Q2 2018
32.95
44.08
55.2
66.33
Details
Expected EPS
N/A
Actual EPS
66.3286
Surprise EPS
66.33
Surprise Percent
+∞%
Description
Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 66.3286 per share for Q2 2018.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist